China Resources Pharmaceutical Group Limited (HKG:3320)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
5.22
-0.02 (-0.38%)
Mar 28, 2025, 4:08 PM HKT

HKG:3320 Revenue

In the year 2024, China Resources Pharmaceutical Group had annual revenue of 257.67B CNY with 5.30% growth. China Resources Pharmaceutical Group had revenue of 129.08B in the half year ending December 31, 2024, with 20.66% growth.

Revenue
257.67B CNY
Revenue Growth
+5.30%
P/S Ratio
0.12
Revenue / Employee
3.54M CNY
Employees
72,700
Market Cap
32.79B HKD

Revenue Chart

* This company reports financials in CNY.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024257.67B12.97B5.30%
Dec 31, 2023244.70B26.52B12.16%
Dec 31, 2022218.18B-18.62B-7.86%
Dec 31, 2021236.81B36.38B18.15%
Dec 31, 2020200.42B-4.03B-1.97%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

China Resources Pharmaceutical Group News

More News